Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevalence of side effects of risperidone in patients with schizophrenia
IRCT201011225147N2Phase 3Completed
- Sponsor
- Yasouj University of Medical Sciences
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of risperidone in schizophrenia, sponsored by Yasouj University of Medical Sciences. Primary endpoint: Prevalence of risperidone side effects. Started Apr 2010; status: completed.
02
Drugs
risperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT201011225147N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201011225147N2.